机译:PTTG表达与垂体腺瘤侵袭性和微血管密度的关系:Meta分析
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;
Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University Nanjing Street No. 155 Heping District Shenyang 110001 People's Republic of China;
机译:垂体腺瘤的MRI侵袭性特征与EMMPRIN,galectin-3表达和微血管密度之间的关系。
机译:垂体腺瘤中垂体肿瘤转化基因(PTTG)的免疫组织化学表达:肿瘤亚型的相关研究。
机译:非功能性垂体腺瘤的PTTG过表达:与侵袭性,女性性别和较年轻的年龄相关
机译:侵袭性垂体腺瘤中基质金属蛋白酶及其抑制剂的表达
机译:胰岛素与人肿瘤发生中垂体肿瘤转化基因(PTTG)之间的相互关系。
机译:人类垂体肿瘤转化基因(PTTG)通过增加基质金属蛋白酶-2(MMP-2)的表达和分泌来调节血管生成和侵袭
机译:垂体肿瘤转化基因(PTTG)在垂体腺瘤中的表达